JNJ vs BAX
By Alex · Tickerpine
Johnson & Johnson vs Baxter International Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | JNJ | BAX |
|---|---|---|
| Price | $260.86 | $26.95 |
| Market cap | $628.65B | $13.93B |
| P/E ratio | 30.3 | — |
| ROE | 25.74% | -14.37% |
| Profit margin | 21.48% | -9.27% |
| Revenue growth | 6.60% | 5.30% |
| Dividend yield | 2.05% | 0.14% |
| Beta | 0.23 | 0.59 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
JNJ vs BAX in plain English
- JNJ is the bigger company — about 45.1× the market cap of BAX.
- JNJ earns a higher return on equity (26% vs -14%).
- JNJ is growing revenue faster (7% vs 5%).
- JNJ has the higher dividend yield (2.05% vs 0.14%).
How would $1,000 have done in each?
JNJ return calculator
See what $1,000 in Johnson & Johnson would be worth today.
BAX return calculator
See what $1,000 in Baxter International Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.